Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06014086 · ClinicalTrials.gov registry record · Phase 1
Intratumoral PH-762 for Cutaneous Carcinoma
A Phase 1 study of Merkel Cell Carcinoma of Skin and Squamous Cell Carcinoma of the Skin, sponsored by Phio Pharmaceuticals.
- Active
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 5
- Study locations
NCT06014086 is a Phase 1 study of Merkel Cell Carcinoma of Skin and Squamous Cell Carcinoma of the Skin that is active but no longer recruiting, run by Phio Pharmaceuticals. The registered enrollment target is 30 participants. The trial reports 5 study locations across 5 states.
The verdict
NCT06014086, a Phase 1 study of Merkel Cell Carcinoma of Skin and Squamous Cell Carcinoma of the Skin, is active but no longer recruiting, sponsored by Phio Pharmaceuticals.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 5
- Study locations
Study Summary
The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug. Participants will receive four injections of PH-762 at weekly intervals, into a single tumor, followed by surgical removal of the tumor approximately two weeks later.
Conditions Studied
Interventions
- DRUG PH-762
Study Locations (5)
Arizona
- Banner MD Anderson Cancer Center - Gilbert
California
- Paradigm Clinical Research - San Diego
Florida
- Integrity Research - Delray Beach
Nevada
- Skin Cancer and Dermatology Institute - Reno
Ohio
- Centricity Research - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2023-11-07 |
| Est. Completion | 2026-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06014086
The ClinicalTrials.gov registry entry for NCT06014086 describes a study currently listed as active not recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Phio Pharmaceuticals, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 3 conditions, with Merkel Cell Carcinoma of Skin appearing as the primary indexed condition, and to 1 intervention - of which PH-762 is the first listed.
NCT06014086 reports 5 study locations spanning 5 distinct geographic areas - top geographies include Arizona, California, Florida.
Frequently Asked Questions
What is clinical trial NCT06014086 about?
NCT06014086 is a clinical study titled "Intratumoral PH-762 for Cutaneous Carcinoma". The goal of this clinical trial is to evaluate the safety and tolerability of intratumoral injections of PH-762 in squamous cell carcinoma, melanoma, or Merkel cell carcinomas of the skin, to understand what the body does to the PH-762, and to observe how the tumor responds to the drug. Participants...
What is the current status of trial NCT06014086?
This trial is currently active not recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2023-11-07. Estimated completion is 2026-03.
What conditions does trial NCT06014086 study?
This clinical trial studies the following conditions: Merkel Cell Carcinoma of Skin, Squamous Cell Carcinoma of the Skin, Malignant Melanoma of Skin.
What interventions are being tested in trial NCT06014086?
The interventions under investigation include: PH-762 (DRUG).
Who is sponsoring clinical trial NCT06014086?
This trial is sponsored by Phio Pharmaceuticals, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06014086 being conducted?
This trial has 5 study locations across Arizona, California, Florida, Nevada, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Merkel Cell Carcinoma of Skin
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Merkel Cell Carcinoma of Skin
All registered trials for this condition
Squamous Cell Carcinoma of the Skin
All registered trials for this condition
Arizona
All trials with a study site in Arizona
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.